Betaine

Betaine

SCHEMBL514681

C=C(C)CNCCC[N+](C)(C)CCCS(=O)(=O)O.C[N+](C)(C)CC(=O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Betaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
APEX1 P27695 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Betaine SCHEMBL3946024 0.95 TSHR (0.35) TSHRALDH1A1LMNAAPEX1
SCHEMBL7722290 0.89 BBOX1 (0.32)
Water SCHEMBL170463 0.88 BBOX1 (0.31)
Betaine SCHEMBL5613071 0.82 TSHR (0.35) TSHRALDH1A1LMNAAPEX1
Betaine SCHEMBL3265675 0.80 TSHR (0.33) TSHRALDH1A1LMNAAPEX1
Betaine SCHEMBL11147482 0.79 TSHR (0.39) TSHRALDH1A1LMNAAPEX1
Betaine SCHEMBL6917420 0.78 TSHR (0.38) TSHRALDH1A1LMNAAPEX1
Betaine SCHEMBL7991073 0.78 TSHR (0.35) TSHRALDH1A1LMNAAPEX1
SCHEMBL173751 0.77 BBOX1 (0.49) LMNA
Glycinebetaine SCHEMBL5166113 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2544812-B1 IMPROVED MICROCAPSULES AND PRODUCTION THEREOF FOLLMANN GMBH & CO KG (DE) 2018-10-24 EP claimed
EP-1902077-B2 NEUTRALISED CATIONIC POLYMER, COMPOSITION CONTAINING SAID POLYMER AND A COSMETIC TREATMENT METHOD OREAL (FR) 2018-07-18 EP claimed
US-10004923-B2 Neutralised cationic polymer, composition containing said polymer and a cosmetic treatment method L'OREAL (FR) 2018-06-26 US claimed
US-20160177002-A1 HYDROGEL FIBERS AND PREPARATION THEREOF INTELLISIV LTD. (IL) 2016-06-23 US claimed
EP-3027233-A1 HYDROGEL FIBERS AND PREPARATION THEREOF Intellisiv Ltd (IL) 2016-06-08 EP claimed
US-9359461-B2 Ethylene copolymers, compositions comprising same and preparation and treatment methods L'OREAL (FR) 2016-06-07 US claimed
EP-2705062-B1 SHEAR STABLE POLYMERS, THEIR PREPARATION AND THEIR USE AS THICKENER RHODIA OPERATIONS (FR) 2016-03-23 EP claimed
US-9196405-B2 Stable iron oxide nanoparticles and method of production FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2015-11-24 US claimed
US-9056125-B2 Films for controlled cell growth and adhesion FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2015-06-16 US claimed
WO-2015015500-A1 HYDROGEL FIBERS AND PREPARATION THEREOF INTELLISIV LTD. (IL) 2015-02-05 WO claimed
EP-1768643-A2 COSMETIC COMPOSITIONS CONTAINING AT LEAST ONE SURFACTANT AND AT LEAST ONE ETHYLENE COPOLYMER WITH POLYETHYLENE GLYCOL GRAFTS L'OREAL (FR) 2007-04-04 EP claimed
EP-1769011-A2 NOVEL ETHYLENE COPOLYMERS, COMPOSITIONS CONTAINING SAID COPOLYMERS AND TREATMENT METHOD L'Oréal (FR) 2007-04-04 EP claimed
EP-1765893-A2 NOVEL ETHYLENE COPOLYMERS, COMPOSITIONS COMPRISING SAME AND PREPARATION AND TREATMENT METHODS L'Oréal (FR) 2007-03-28 EP claimed
WO-2007003784-A1 NEUTRALISED CATIONIC POLYMER, COMPOSITION CONTAINING SAID POLYMER AND A COSMETIC TREATMENT METHOD L'OREAL (FR) 2007-01-11 WO claimed
EP-1732964-A2 SEQUENCED COPOLYMER Arkema France (FR) 2006-12-20 EP claimed
WO-2006013269-A2 NOVEL ETHYLENE COPOLYMERS, COMPOSITIONS COMPRISING SAME AND PREPARATION AND TREATMENT METHODS L'OREAL (FR) 2006-02-09 WO claimed
WO-2006013270-A2 COSMETIC COMPOSITIONS CONTAINING AT LEAST ONE SURFACTANT AND AT LEAST ONE ETHYLENE COPOLYMER WITH POLYETHYLENE GLYCOL GRAFTS L'ORÉAL (FR) 2006-02-09 WO claimed
WO-2006013268-A2 NOVEL ETHYLENE COPOLYMERS, COMPOSITIONS CONTAINING SAID COPOLYMERS AND TREATMENT METHOD L'OREAL (FR) 2006-02-09 WO claimed
US-20050287111-A1 Films for controlled cell growth and adhesion FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2005-12-29 US claimed
WO-2005103102-A2 SEQUENCED COPOLYMER ARKEMA FRANCE (FR) 2005-11-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10004923-B2 Neutralised cationic polymer, composition containing said polymer and a cosmetic treatment method KRT18, EYA3, EYA2 TSHR 1215/4885ALDH1A1 3858/4885LMNA 2637/4885
US-20050287111-A1 Films for controlled cell growth and adhesion PCNA, FIBP, FSCN1 TSHR 1078/4885ALDH1A1 4613/4885LMNA 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.